Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05NDR
|
||||
Former ID |
DCL000640
|
||||
Drug Name |
Sifalimumab
|
||||
Drug Type |
Antibody
|
||||
Company |
AstraZeneca; MedImmune
|
||||
Structure |
Download2D MOL |
||||
Formula |
C56H87NO16
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Interferon-alpha/beta receptor | Target Info | [550288], [551134] | ||
References | |||||
Ref 529282 | 2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9. | ||||
Ref 543015 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8257). | ||||
Ref 551134 | Clinical pipeline report, company report or official report of MedImmune (2011). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.